跳至主要内容
临床试验/CTRI/2019/01/016921
CTRI/2019/01/016921招募中未知

Finding the effect of Vitamin D supplementation on coronary artery diseases in type 2 diabetes: Focusing on glycemic control, cardiac function and immunomodulation.

ational Institute of Pharmaceutical Education and ResearchGuwahati0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Inclusion criteria for Type 2 diabetes group
  • Age > 25 to 65 years
  • Male and female patients included
  • HbA1C levels >=7 % to <=10 at visit 1
  • Total 25 (OH) D levels < 20 ng/ml
  • Inclusion criteria for Type 2 diabetes with coronary artery diseases (T2DM_CAD)
  • Age > 25 to 65 years
  • Male and female patients included
  • HbA1C levels >=7 % to <=10
  • Documented acute myocardial infarction, narrowing, or blockage of one or more epicardial coronary artery with greater than 25% stenosis shown in coronary angiography and diagnosed by cardiologists.

排除标准

  • Exclusion Criteria for Type 2 diabetes group
  • SBP/DBP >=140/100 mmHg.
  • Subjects on Insulin therapy
  • Prior vitamin D therapy
  • Subjects with any cardiovascular complications and chronic diseases
  • Exclusion Criteria for Type 2 diabetes with coronary artery diseases (T2DM_CAD)
  • Exclusion criteria defined for this study is prior treatment with vitamin D, clinical or laboratory evidence of liver failure, renal failure (plasma creatinine levels > 1.5 mg/dl), Type 1 diabetes, cancer, thyroid disease, and pregnancy

研究者

发起方
ational Institute of Pharmaceutical Education and ResearchGuwahati

相似试验